Kelly M. Hatfield

Kelly M. Hatfield

Auto-generated profile, based on publicly available information

Kelly M. Hatfield

Centers for Disease Control and Prevention

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2017 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JBJames Baggs
James Baggs
JJJohn A Jernigan
John A Jernigan
AHAlison Laufer Halpin
Alison Laufer Halpin
LELauren Epstein
Lauren Epstein
KHKelly M Hatfield
Kelly M Hatfield
LML Clifford McDonald
L Clifford McDonald
We examined the risk of sepsis within 90 days after discharge from a previous hospital stay by type of antibiotic received during the previous stay. We retrospectively identified a cohort of hospitalized patients from the Truven Health MarketScan Hospital Drug Database. We examined the association between the use of certain antibiotics during the initial hospital stay, determined a priori, and the risk of postdischarge sepsis controlling for potential confounding factors in a multivariable logistic regression model. Our primary exposure was receipt of antibiotics more strongly associated with clinically important microbiome disruption. Our primary outcome was a hospital stay within 90 days of the index stay that included an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) discharge diagnosis of severe sepsis (ICD-9-CM code 995.92) or septic shock (785.52). Among 516 hospitals, we randomly selected a single stay for eligible patients. In 0.17% of these patients, severe sepsis/septic shock developed within 90 days after discharge. The risk of sepsis associated with exposure to our high-risk antibiotics was 65% higher than in those without antibiotic exposure. Our study identified an increased risk of sepsis within 90 days of discharge among patients with exposure to high-risk antibiotics or increased quantities of antibiotics during hospitalization. Given that a significant proportion of inpatient antimicrobial use may be unnecessary, this study builds on previous evidence suggesting that increased stewardship efforts in hospitals may not only prevent antimicrobial resistance, Clostridium difficile infection, and other adverse effects, but may also reduce unwanted outcomes potentially related to disruption of the microbiota, including sepsis.

1 July 2021 in Annals of Internal Medicine
Verified
Journal Article
Open access
SMSusannah L McKay
Susannah L McKay
FTFarrell A Tobolowsky
Farrell A Tobolowsky
EMErin D Moritz
Erin D Moritz
KHKelly M Hatfield
Kelly M Hatfield
ABAmelia Bhatnagar
Amelia Bhatnagar
PKPreeta K Kutty
Preeta K Kutty
It has been hoped that rapid SARS-CoV-2 antigen testing could reduce the tragic toll of COVID-19 in nursing homes. The performance of the BinaxNOW antigen test in a nursing home during an ongoing S... Visual Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak. It has been hoped that rapid SARS-CoV-2 antigen testing could reduce the tragic toll of COVID-19 in nursing h... Background: To address high COVID-19 burden in U.S. nursing homes, rapid SARS-CoV-2 antigen tests have been widely distributed in those facilities. However, performance data are lacking, especially...

6 November 2017 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
SYSarah H Yi
Sarah H Yi
KHKelly M Hatfield
Kelly M Hatfield
JBJames Baggs
James Baggs
LHLauri A Hicks
Lauri A Hicks
ASArjun Srinivasan
Arjun Srinivasan
JJJohn A Jernigan
John A Jernigan
Previous studies suggest that duration of antibiotic therapy for community-acquired pneumonia (CAP) often exceeds national recommendations and might represent an important opportunity to improve antibiotic stewardship nationally. Our objective was to determine the average length of antibiotic therapy (LOT) for patients treated for uncomplicated CAP in US hospitals and the proportion of patients with excessive durations. Records of retrospective cohorts of patients aged 18–64 years with private insurance and aged ≥65 years with Medicare hospitalized for CAP in 2012–2013 were used. Inpatient LOT was estimated as a function of length of stay. Outpatient LOT was based on prescriptions filled post discharge based on data from outpatient pharmacy files. Excessive duration was defined as outpatient LOT >3 days. Inclusion criteria were met for 22128 patients aged 18–64 years across 2100 hospitals and 130746 patients aged ≥65 years across 3227 hospitals. Median total LOT was 9.5 days. LOT exceeded recommended duration for 74% of patients aged 18–64 years and 71% of patients aged ≥65 years. Patients aged 18–64 years had a median (quartile 1–quartile 3) 6 (3–7) days outpatient LOT and those aged ≥65 years had 5 (3–7) days. In this nationwide sample of patients hospitalized for CAP, median total LOT was just under 10 days, with more than 70% of patients having likely excessive treatment duration. Better adherence to recommended CAP therapy duration by improving prescribing at hospital discharge may be an important target for antibiotic stewardship programs.

1 November 2018 in Critical Care Medicine
Verified
Journal Article
Closed access
KHKelly M. Msph Hatfield
Kelly M. Msph Hatfield
RDRaymund B. Dantes
Raymund B. Dantes
JBJames Baggs
James Baggs
MSMathew R. P. Sapiano
Mathew R. P. Sapiano
AFAnthony E. Fiore
Anthony E. Fiore
LELauren Md Epstein
Lauren Md Epstein
Objectives: To assess the variability in short-term sepsis mortality by hospital among Centers for Medicare and Medicaid Services beneficiaries in the United States during 2013–2014. Design: A retrospective cohort design. Setting: Hospitalizations from 3,068 acute care hospitals that participated in the Centers for Medicare and Medicaid Services inpatient prospective payment system in 2013 and 2014. Patients: Medicare fee-for-service beneficiaries greater than or equal to 65 years old who had an inpatient hospitalization coded with present at admission severe sepsis or septic shock. Interventions: None. Measurements and Main Results: Individual level mortality was assessed as death at or within 7 days of hospital discharge and aggregated to calculate hospital-level mortality rates. We used a logistic hierarchal linear model to calculate mortality risk-adjusted for patient characteristics. We quantified variability among hospitals using the median odds ratio and calculated risk-standardized mortality rates for each hospital. The overall crude mortality rate was 34.7%. We found significant variability in mortality by hospital (p < 0.001). The middle 50% of hospitals had similar risk-standardized mortality rates (32.7–36.9%), whereas the decile of hospitals with the highest risk-standardized mortality rates had a median mortality rate of 40.7%, compared with a median of 29.2% for hospitals in the decile with the lowest risk-standardized mortality rates. The median odds ratio (1.29) was lower than the adjusted odds ratios for several measures of patient comorbidities and severity of illness, including present at admission organ dysfunction, no identified source of infection, and age. Conclusions: In a large study of present at admission sepsis among Medicare beneficiaries, we showed that mortality was most strongly associated with underlying comorbidities and measures of illness on arrival. However, after adjusting for patient characteristics, mortality also modestly depended on where a patient with sepsis received care, suggesting that efforts to improve sepsis outcomes in lower performing hospitals could impact sepsis survival.

10 July 2020 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
GSGuillermo V Sanchez
Guillermo V Sanchez
CBCaitlin Biedron
Caitlin Biedron
LFLauren R Fink
Lauren R Fink
KHKelly M Hatfield
Kelly M Hatfield
JPJordan Micah F Polistico
Jordan Micah F Polistico
NRNajibah K Rehman
Najibah K Rehman
This report describes initial and repeated point prevalence surveys used to detect COVID-19 cases across 26 skilled nursing facilities in Detroit.

7 January 2019 in Clinical Infectious Diseases
Verified
Journal Article
Open access
AGAlice Y Guh
Alice Y Guh
KHKelly M Hatfield
Kelly M Hatfield
LWLisa G Winston
Lisa G Winston
BMBrittany Martin
Brittany Martin
HJHelen Johnston
Helen Johnston
LML Clifford McDonald
L Clifford McDonald
Background: Few data suggest that Clostridioides difficile infections (CDIs) detected by toxin enzyme immunoassay (EIA) are more severe and have worse outcomes than those detected by nucleic acid amplification tests (NAATs) only. We compared toxin- positive and NAAT-positive-only CDI across geographically diverse sites. Methods: A case was defined as a positive C. difficile test in a person ≥1 year old with no positive tests in the prior 8 weeks. Cases were detected during 2014–2015 by a testing algorithm (specimens initially tested by glutamate dehydrogenase and toxin EIA; if discordant results, specimens were reflexed to NAAT) and classified as toxin positive or NAAT positive only. Medical charts were reviewed. Multivariable logistic regression models were used to compare CDI-related complications, recurrence, and 30-day mortality between the 2 groups. Results: Of 4878 cases, 2160 (44.3%) were toxin positive and 2718 (55.7%) were NAAT positive only. More toxin-positive than NAAT-positive-only cases were aged ≥65 years (48.2% vs 38.0%; P < .0001), had ≥3 unformed stools for ≥1 day (43.9% vs 36.6%; P < .0001), and had white blood cell counts ≥15 000 cells/µL (31.4% vs 21.4%; P < .0001). In multivariable analysis, toxin positivity was associated with recurrence (adjusted odds ratio [aOR], 1.89; 95% confidence interval [CI], 1.61–2.23), but not with CDI-related complications (aOR, 0.91; 95% CI, .67–1.23) or 30-day mortality (aOR, 0.95; 95% CI, .73–1.24). Conclusions: Toxin-positive CDI is more severe, but there were no differences in adjusted CDI-related complication and mortality rates between toxin-positive and NAAT-positive-only CDI that were detected by an algorithm that utilized an initial glutamate dehydrogenase screening test.